AI Governance Institute logo
AI Governance Institute

Intelligence for Compliance and GRC Teams

← News
Research2026-04-22

AI deregulation shifts risk to private sector, Harvard Ethics Center's Boundaries of Tolerance Framework finds

What happened

The Harvard Ethics Center published an analysis on November 1, 2025, titled AI Governance at a Crossroads: America's AI Action Plan and Its Impact on Businesses, examining how the United States AI Action Plan reshapes compliance obligations for private sector organizations. The analysis finds that the Action Plan deliberately reduces federal oversight in favor of innovation-led development, transferring primary responsibility for AI risk management to individual companies. In response, Harvard researchers introduce the Boundaries of Tolerance Framework, a structured corporate governance tool designed to help organizations formally define, document, and justify the range of AI-related risks they consider acceptable across development and deployment contexts. The framework is positioned as a functional substitute for absent federal standards, particularly for organizations operating outside heavily regulated sectors such as financial services or healthcare. The publication signals that internal risk tolerance documentation may increasingly serve as a de facto governance instrument in the absence of binding federal rules.

Why it matters

  • ·The deliberate reduction of federal AI oversight under the US AI Action Plan creates regulatory exposure for organizations that have relied on anticipated federal standards to anchor their governance programs, leaving them without a clear external compliance benchmark.
  • ·Organizations in financial services, healthcare, and other regulated industries must now reconcile voluntary frameworks like the Boundaries of Tolerance Framework with existing sector-specific obligations from regulators such as the OCC, CFPB, and HHS, increasing operational complexity.
  • ·Companies outside regulated sectors face heightened organizational risk because documented risk tolerance policies may face scrutiny from investors, auditors, or future regulators, and the absence of formalized internal governance documentation could be treated as a governance failure.

Governance controls affected

ALC-001AI Decision LoggingCMP-001Multi-Jurisdiction AI Regulatory Compliance MappingCMP-007EU AI Act Conformity Assessment and FRIA ProcessHOC-001AI Risk ClassificationHOC-002Human Approval RequirementsHOC-004Meaningful Human Review StandardMON-005Model Card and Documentation Maintenance

What to do now

  • ☐Conduct a gap assessment of existing AI governance documentation to determine whether it is sufficient to demonstrate defensible risk management decisions in the absence of binding federal requirements.
  • ☐Map the Boundaries of Tolerance Framework against sector-specific regulatory obligations under the OCC, CFPB, or HHS to identify conflicts or coverage gaps for regulated-industry deployments.
  • ☐Draft or update formal risk tolerance policies that define acceptable risk ranges for AI development and deployment, treating these documents as audit-ready governance instruments.
  • ☐Brief executive leadership and board-level risk committees on the implications of the US AI Action Plan deregulatory shift and the increased governance burden now placed on the private sector.
  • ☐Establish a monitoring process to track how investors, auditors, and sector-specific regulators are interpreting voluntary AI governance frameworks as proxies for compliance standards.

What to watch next

Compliance teams should monitor whether US sector-specific regulators such as the OCC, CFPB, and HHS issue formal guidance clarifying how voluntary frameworks like the Boundaries of Tolerance Framework interact with existing supervisory expectations for AI risk management. Enforcement actions or supervisory letters from these agencies referencing internal risk documentation standards would signal that self-governance materials are being treated as de facto compliance instruments. Teams should also track developments in the EU AI Act implementation timeline, as the contrast between binding EU requirements and the US deregulatory posture may create divergent compliance obligations for multinational organizations.

Stay ahead of stories like this

Get every US AI governance development like this one, plus the rest of the week's developments. Every Thursday.

Powered by Buttondown.

Related Coverage

Research2026-07-24

S&P Global Identifies Five Governance Principles That Should Anchor Every Enterprise AI Risk Program

S&P Global has published a research report titled 'The AI Governance Challenge' identifying transparency, fairness, privacy, adaptability, and accountability as the five core principles that should structure enterprise AI governance programs. The report is addressed to enterprise risk and compliance leaders and offers design guidance for documentation standards, bias review processes, privacy impact assessments, and accountability structures. It carries no regulatory force but reflects an emerging market consensus from a recognized financial intelligence institution.

Research2026-07-26

Algorithm Registries and Third-Party Audit Models from Smart City Governance Offer a Transferable Blueprint for Enterprise Transparency Programs

RAISEF AI published a case study examining responsible AI governance patterns in smart city and urban public-sector deployments, including algorithm registries, localized performance dashboards, and third-party audits of public-facing models. The study identifies these mechanisms as transferable to enterprise settings, where transparency and auditability obligations are increasing. It recommends structured disclosure processes that preserve sensitive implementation details while satisfying external accountability requirements.

Enforcement2026-07-21

CMS WISeR Pilot Puts AI-Driven Denial Decisions Under Federal Scrutiny, Exposing Vendor Incentive and Human Oversight Failures

The Centers for Medicare and Medicaid Services launched the WISeR pilot in six U.S. states, using AI and machine learning to automate prior authorization decisions in original Medicare through December 2031. Critics and a 2025 AMA survey of physicians document early evidence of wrongful denials and care delays, while the vendor payment model ties compensation to 'averted expenditures,' creating a structural conflict of interest. The pilot exposes governance gaps in algorithmic accountability, explainability, and meaningful human review that apply well beyond federal healthcare programs.